Calling all income investors! Two dividend kinds deserve your attention in 2025: Colgate-Palmolive (NYSE:CL) and Emerson ...

JP Morgan analyst Andrea Teixeira maintained Colgate-Palmolive with an Overweight rating and raised the price target from $95 ...

Colgate-Palmolive posted a higher profit in the first quarter but lowered 2025 earnings guidance due to tariffs.

The owner of skin care brand Sanex is also expecting a price hike on sold goods as a result of US President Donald Trump’s ...

We look at Colgate-Palmolive Company's Q1 results, market challenges, and tariff impacts. Read to see if the CL stock is ...

Colgate-Palmolive on Friday reported better-than-expected first-quarter results and lifted its full-year sales outlook, ...

Organic sales rose 1.4% during the quarter, with pricing up 1.5% and volume down 0.1%. The impact of FX was a negative 4.4% ...

Colgate-Palmolive surpassed earnings expectations in Q1 2025, despite experiencing a decline in overall sales.

JP Morgan analyst Andrea Teixeira maintained an Overweight rating and slashed the price target from $99 to $95 on April 11, ...

Colgate-Palmolive alum Elaine Paik will step into the skincare brand’s top financial seat and will also lead the company’s ...

Makers of our food and home essentials, including Pepsi and Procter & Gamble, are cutting their financial forecasts for the ...

Higher costs could further dampen consumer demand. For Colgate, tariffs will drive raw and packaging materials costs higher ...